Photocatalytic Pt(IV)‐Coordinated Carbon Dots for Precision Tumor Therapy
Open Access
- 28 October 2022
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 9 (36)
Abstract
Rapid, efficient, and precise cancer therapy is highly desired. Here, this work reports solvothermally synthesized photoactivatable Pt(IV)‐coordinated carbon dots (Pt‐CDs) and their bovine serum albumin (BSA) complex (Pt‐CDs@BSA) as a novel orange light‐triggered anti‐tumor therapeutic agent. The homogeneously distributed Pt(IV) in the Pt‐CDs (Pt: 17.2 wt%) and their carbon cores with significant visible absorption exhibit excellent photocatalytic properties, which not only efficiently releases cytotoxic Pt(II) species but also promotes hydroxy radical generation from water under orange light. When triggered with a 589 nm laser, Pt‐CDs@BSA possesses the ultrastrong cancer cell killing capacities of intracellular Pt(II) species release, hydroxyl radical generation, and acidification, which induce powerful immunogenic cell death. Activation of Pt‐CDs@BSA by a single treatment with a 589 nm laser effectively eliminated the primary tumor and inhibited distant tumor growth and lung metastasis. This study thus presents a new concept for building photoactivatable Pt(IV)‐enriched nanodrug‐based CDs for precision cancer therapy.Keywords
Funding Information
- National Natural Science Foundation of China (61922091, 82030094, 52203160)
This publication has 53 references indexed in Scilit:
- Immunogenic cell death in cancer and infectious diseaseNature Reviews Immunology, 2016
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) ProdrugsChemical Reviews, 2016
- The Interplay of Size and Surface Functionality on the Cellular Uptake of Sub-10 nm Gold NanoparticlesACS Nano, 2015
- Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapyNature, 2015
- Metal-free efficient photocatalyst for stable visible water splitting via a two-electron pathwayScience, 2015
- Cisplatin-Induced Antitumor Immunomodulation: A Review of Preclinical and Clinical EvidenceClinical Cancer Research, 2014
- Disrupting proton dynamics and energy metabolism for cancer therapyNature Reviews Cancer, 2013
- Immunogenic cell death and DAMPs in cancer therapyNature Reviews Cancer, 2012
- Interfering with pH regulation in tumours as a therapeutic strategyNature Reviews Drug Discovery, 2011
- WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activityNature, 2008